Price $70.55 |
Market Cap
22.8B
|
Sector Health Care |
Div. Growth
12.10%
|
|
P/E
20.8
|
P/B
4.53
|
P/S
4.62
|
Dividend %
0.90%
|
|
P/CF
-
|
P/FCF
34.3
|
Op. Cash Flow
1.03M
|
FCF
2.1
|
|
Op. Margin
18.70%
|
Net Margin
22.30%
|
ROE
23.20%
|
ROI
13.60%
|
|
ROA
12.80%
|
EPS Growth
373.80%
|
Current Ratio
3.3
|
Debt/Equity
39.40%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Novelion Therapeutics Inc (USA (NVLN) | $0.74 | - | - | 15.6M | Strong Buy |
| Esperion Therapeutics Inc (ESPR) | $45.51 | - | - | 1.31B | Strong Buy |
| Spectral Medical Inc (EDTXF) | $0.29 | - | - | 62.6M | Strong Buy |
| Dynatronics Corporation (DYNT) | $1.74 | - | - | 14.6M | Strong Buy |
| Delcath Systems, Inc. (DCTH) | $0.08 | - | - | 2.1M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
